STOP T1D

11/06/2025

Take a look at our newly updated website and CME learning modules!

We've added some features that make it easier and more fun to learn online about screening, diagnoses, and monitoring:

✓ Website and learning modules optimized for mobile users
✓ ChatBot ready to answer your questions
✓ Newly updated and expanded content
✓ Play-on-demand audio narration accompanying charts, figures, tables, and images
✓ Information about the Early T1D Registry
✓ Additional resources inside the learning modules for HCPs

STOP T1D provides a type 1 diabetes education program for HCPs, developed by the researchers and physicians at the Barbara Davis Center for Diabetes in Aurora, Colorado (BarbaraDavisCenter.org).

STOPT1Dprogram.org offers , , and professionals FREE Continuing Medical Education (CME) credits through online learning that you can access any time it's convenient for you.

Take the course modules at your own pace. Most people complete them in a couple of hours. Course modules cover:
• Screening methods and confirmation
• Target populations
• Communication of results
• Patient monitoring
• Available intervention and clinical trial opportunities
• Implementation of screening and monitoring into health systems

Earn credits while advancing your knowledge and awareness on the importance of T1D screenings.

visit https://www.stopt1dprogram.org/for-hcp to review the program and register for free.

Welcome to STOP T1D — Screen TO Prevent Type 1 Diabetes — an educational program for health care providers. Individuals/families who have screened positive for T1D autoantibodies may join the STOP T1D Registry, and find helpful LINKS to other T1D resources.

11/06/2025

There's still time to register for the 8th Symposium on General Population Screening for ! Attend in-person or online.

11/05/2025

It's - and we're serving up some facts to increase your awareness.

From the American Diabetes Association ( ):

✅ Prevalence of diabetes in seniors: The percentage of Americans age 65+ is high (29.2%, or 16.5 million seniors; diagnosed and undiagnosed).
✅ New cases: 1.2 M Americans are diagnosed with diabetes every year.
✅ Prediabetes: In 2021, 97.6 million Americans age 18 and older had prediabetes.
✅ About 352,000 Americans under age 20 are estimated to have diagnosed diabetes (approximately 0.35% of that population).
✅ In 2017–2018, the annual incidence of diagnosed diabetes in youth was estimated at 18,200 with type 1 diabetes ( ), 5,300 with type 2 diabetes ( ).

source: https://diabetes.org/about-diabetes/statistics/about-diabetes

11/04/2025

"Compared with standard insulin regimens, automated insulin delivery ( ) systems used for 6 months or longer were associated with better glycemic control — including increased time in range and lower A1c levels — without an increased risk for adverse events in youth aged 6-18 years with ( ). Certain benefits were particularly notable during nighttime."

Automated Insulin Delivery Boosts Glycemic Control in Youth https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3

health

Youth with type 1 diabetes experience better glycemic control with prolonged use of automated insulin delivery systems than with standard insulin regimens, according to a meta-analysis.

11/03/2025

November is National Diabetes Awareness Month, so we'll be sharing some facts this month to help raise awareness.

U.S. DIABETES FACTS:
💧 38.4 million people have diabetes in the United States (11.6% of the U.S. population)
💧 29.7 million people, including 29.4 million adults have been diagnosed with diabetes in the U.S.
💧 8.7 million people are estimated to remain undiagnosed with diabetes (22.8% of adults with diabetes are undiagnosed).

Get screened for type 1 diabetes!

The ASK screening program (ASKhealth.org) provides no-cost screenings for children as young as age one and adults for and disease.

The STOP T1D program provides a free course online for health care providers ( ). Learn more at STOPT1Dprogram.org


Source: https://www.cdc.gov/diabetes/php/data-research/index.html

10/31/2025

Well, this is exciting news in !

From Breakthrough T1D: "Baricitinib is a JAK inhibitor that interferes with signaling pathways critical to both immune cells and beta cells. This drug has the potential to extend the “honeymoon period” of , meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications."

Two new trials investigating baricitinib to delay T1D - Breakthrough T1D https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/

Eli Lilly announced that they are launching two clinical trials to see if baricitinib can delay type 1 diabetes (T1D) onset or progression.

10/30/2025

CGM May Aid Cystic Fibrosis-Related Diabetes Screening https://www.medscape.com/viewarticle/cgm-may-aid-cystic-fibrosis-related-diabetes-screening-2025a1000tdo

"Continuous glucose monitoring (CGM)-derived metrics reliably identified cystic fibrosis-related diabetes in patients with cystic fibrosis. Additionally, a novel way of analysing data called glucodensity, which shows how often glucose levels fall into different ranges, worked better than A1c and standard CGM measures in detecting early cystic fibrosis-related diabetes."

Glucodensities, a composite continuous glucose monitoring index, outperform A1c and standard continuous glucose monitoring metrics in diagnosing cystic fibrosis-related diabetes.

10/29/2025

What is the STOP T1D Registry?

The purpose of the STOP T1D Registry is to improve the quality of screening and monitoring for (T1D) in the United States. We are doing this by collecting information* from people who have been screened and tested positive for pre-symptomatic (autoantibodies), regardless of whether they have been later diagnosed with symptomatic Stage 3 T1D.

Learn more: https://www.stopt1dprogram.org/registry-overview

Health care providers are invited to participate in STOP T1D — a comprehensive educational program for T1D screening and monitoring — from the Barbara Davis Center for Diabetes at the University of Colorado, Anschutz Medical Campus, Aurora, CO.

Visit: STOPT1Dprogram.org



*For patients under 18 years, we ask their parents/legal guardians to provide the information on their behalf.

Information about the STOP T1D Registry.

10/28/2025

STOP T1D offers a type 1 diabetes education program for health care providers developed by the researchers and physicians at the Barbara Davis Center for Diabetes (BarbaraDavisCenter.org).

STOPT1Dprogram.org provides , , and professionals FREE Continuing Medical Education ( ) credits through online learning that you can access any time it's convenient for you. Take the program modules at your own pace. Most people complete them in a couple of hours.

visit STOPT1Dprogram.org/for-hcp to review the program and take the course for FREE.

10/24/2025

Diabetes Management: Evolution or Revolution? https://diabetesjournals.org/clinical/article/43/4/460/163565/Diabetes-Management-Evolution-or-Revolution

"With all these developments, we have witnessed a shift in the delivery of diabetes health care from specialty to primary care settings. Approximately 85–90% of people with diabetes are seen in primary care, in large part because of the abundance of primary care clinicians, patients’ relative ease of access to primary versus specialty care, and improved diabetes-related expertise among professionals in the primary care setting."

Earlier this year, I had the privilege of providing the keynote address at the American Diabetes Association’s 2025 Clinical Update Conference, where I ref

10/23/2025

The more we know through research, the more we can prepare for and address type 1 diabetes associated health complications.

"The profile of diabetes-related complications is shifting to include nontraditional conditions, such as dementia, cancer, and liver disease. In several high-income countries, mortality due to dementia is higher among individuals with diabetes than among those without diabetes."

"A 2024 study reported that the incidence of neurodegenerative diseases was 1.7-3.4 times higher in patients with , with diabetic nephropathy and cardiovascular disease further increasing the risk for dementia. Brain MRI studies have also linked T1D to focal cerebral atrophy and cerebral small vessel disease."

Is Diabetes Linked to Dementia? Latest Evidence Revealed https://www.medscape.com/viewarticle/diabetes-linked-dementia-latest-evidence-revealed-2025a1000svk

A multinational analysis and Swedish registry data show higher dementia mortality after age 80 and a twofold dementia risk in those with type 1 diabetes.

10/22/2025

New islet research report from the current ADA Diabetes Journal:

researchers aim to codify "our detailed knowledge about the role of human islets in health and disease" where "there is...no current consensus about what size of endocrine structure observed in histological tissue sections in fact constitutes an islet" by "counting of endocrine objects (EOs) in human pancreatic tissue sections."

The report continues: "First off, an explanation is warranted to justify the term EO, defined here as a contiguous histological structure comprised of one or more endocrine cells, and its use in lieu of the more obvious choice of pancreatic islet."

"To better address a multitude of outstanding questions about the physiology of small EOs and their pathological alterations in and beyond, a good start would be consolidated definitions of the terms of engagement that will need to reflect a sensible EO size stratification..."

Sweating the Small Stuff: A Closer Look at the Endocrine Pancreas Throughout Stages of Type 1 Diabetes Progression https://diabetesjournals.org/diabetes/article/74/11/1895/163547/Sweating-the-Small-Stuff-A-Closer-Look-at-the

The task tackled by Drotar et al. (1) in the current issue of Diabetes is seemingly simple; its ex*****on, however, is anything but: the counting of endocr